Microdosing in Canada: What Do You Need to Know in 2023

Here, we look into the intriguing realm of microdosing in Canada and keep you up to date on the most recent advancements in 2023.

Microdosing, or ingesting tiny, sub-perceptual dosages of psychedelics, has received a lot of interest in recent years because of its potential advantages in improving creativity, concentration, and general well-being.

As the psychedelic environment develops and laws change, it is critical to remain up to date on the current condition of microdosing in Canada.

This article will go over all you need to know about microdosing in Canada in 2023, including legal implications, accessible drugs, and the burgeoning research and community around this phenomena.

Join us as we traverse the microdosing environment in Canada and unearth the truths that lie inside this transforming technique, whether you are a curious explorer, an advocate, or just wanting to maximize your own mental health.

What is a Microdose of Magic Mushrooms?

A magic mushroom microdose is a very small amount of mushrooms that contain psilocybin. Psilocybin is the main chemical in these mushrooms that makes people trip.

In contrast to a full or recreational dose, which has strong hallucinatory effects, a microdose is often given at a much smaller dose to make effects that are weak or even unnoticeable.

A microdose of magic mushrooms is a sub-perceptual dose of mushrooms with psilocybin. Compared to a full dose, a microdose has mild affects. Most of the time, 0.1 to 0.3 grams of dried mushrooms are used, but the amount taken each time is smaller.

The benefits of microdosing on happiness, imagination, attention, and well-being vary from person to person. If you’re thinking about microdosing or using any kind of psychedelic drug, it’s important to move slowly, think about the law and your safety, and get advice from medical professionals.

History of Microdosing in Canada

What is a Microdose of Magic Mushrooms?

The history of microdosing in Canada is a fascinating journey of discovery, changes in culture, and changing ideas about psychedelics. Let’s look at the history and major events of microdosing from a Canadian point of view.

Early Scientific Exploration

In the middle of the 20th century, Canada was one of the first places where scientists looked into psychedelics. Researchers and scientists did studies to find out if substances like LSD and psilocybin could be used as medicine.

Notably, Canadian psychiatrist Humphry Osmond worked with English author Aldous Huxley, who is known for his influential book “The Doors of Perception,” in which he wrote about his experiences with psychedelics. Huxley and Osmond worked together on this book.

Counterculture Movement

The counterculture movement of the 1960s, which emphasized individual freedom, the exploration of consciousness, and different ways of living, spread to Canada. Psychedelic drugs became popular with young people who wanted to broaden their views and have more spiritual experiences.

During this time, Timothy Leary’s influence grew. He pushed for people to use psychedelics, like microdosing, to learn more about themselves and change society.

Canada, like many other countries, responded to the growing use of psychedelics by making it illegal to do so. At the beginning of the 1970s, laws were passed to make drugs like LSD and psilocybin illegal.

For many years, these strict rules made it hard to do research and made it hard for people to get psychedelics.

Recent Resurgence and Research

In Canada, there has been a resurgence of interest in psychedelics, like microdosing, in recent years. This is due to changing attitudes in society and new research.

Researchers in Canada are looking into the therapeutic potential of microdosing because of a new interest in psychedelic science and a better understanding of mental health problems.

Studies are being done at places like the University of British Columbia and the Centre for Psychedelic Research at the University of Toronto to find out how microdosing affects mental health problems like depression and anxiety.

Find out more here: Talking to Your Therapist About Psychedelics

Regulatory Changes and Medical Applications

Canada has made important steps toward reforming psychedelics. In August 2020, the Minister of Health gave an exception to psilocybin-assisted therapy for four terminally ill patients.

After this important decision, Health Canada said in August 2022 that it would change the Special Access Program so that healthcare professionals could ask for their patients to have access to restricted substances like psilocybin.

Because of these changes, more research and possible medical uses of microdosing are now possible.

Public Discourse and Cultural Impact

The way people in Canada talk about microdosing is heavily influenced by the media, personal stories, and the opinions of powerful people.

People who have used microdosing as a way to improve their own growth, creativity, and health have told their stories in documentaries, podcasts, and books.

Also, Canadian artists, activists, and researchers have been at the forefront of talks about psychedelics, which has sparked interest and made people more aware of the possible benefits of microdosing.

Future Outlook and Regulation

Canada has made progress in research and access to psychedelics, but the rules about microdosing and psychedelics are still complicated. Finding a good balance between public safety, scientific research, and responsible use is still something that people argue about.

But as research moves forward and public opinion changes, Canada may see more changes in how microdosing is regulated, which could lead to new ways to use it for therapy and more people having access to it.

The history of microdosing in Canada shows a path from early scientific exploration to recent research advances and changes in how people think about it.

As Canada continues to figure out how to regulate psychedelics, the future looks good for learning more about how microdosing can be used as a therapy and how it affects mental health and well-being.

Access to psilocybin for therapeutic use in Canada

In Canada, people who need psilocybin for medical reasons can get it through clinical trials, Health Canada’s Special Access Program, or individual exemptions from the Controlled Drugs and Substances Act (CDSA).

Before asking for an individual exemption, patients should talk to their doctors about treatment options and look into these paths. Clinical trials are the best choice because they meet scientific and ethical standards and keep patients safe.

Good Manufacturing Practices are used to keep the quality of drugs. Health Canada’s Special Access Program lets doctors ask for access to non-marketed drugs, like psilocybin, to treat serious conditions when standard treatments don’t work or aren’t right.

Requests are looked at on a case-by-case basis, with evidence of the drug’s use and patient safety taken into account. Under the CDSA, the Minister of Health can decide to exempt certain people for scientific, medical, or public interest reasons.

Things like legal options, scientific evidence, practitioner support, and goals for public health and safety are all taken into account.

Requests must include a letter of support from a doctor that explains the condition, the options available, the diagnosis, the prognosis, and the treatment plan.

Health Canada stresses how important it is to follow established pathways to make sure patients are safe and have access to psilocybin in a controlled way.

Microdosing, or taking little dosages of psychedelics, is becoming more common in Canada. Changing perspectives of psychedelics are driving the transformation, with scientific research showing their therapeutic value.

The innovative approach taken by Canada to psychedelic research and policy, including the legalization of psilocybin therapy, has sparked interest. Canadians are looking for alternatives to standard drugs for mental health, which has led to rising interest in microdosing.

The legalization of marijuana has also aided in the acceptability of alternative substances. Microdosing has become more accessible due to increased availability to knowledge and internet networks. However, there are still concerns about long-term repercussions and unlawful acquisition.

Despite the increased interest, when considering microdosing, care and educated guidance are required.

Benefits of Microdosing Magic Mushrooms & Other Psychedelics

Magic mushrooms, AKA psilocybin mushrooms, have gained significant attention for their potential therapeutic benefits. These mushrooms contain a compound called psilocybin, which can induce profound psychological and perceptual effects.

Here are 5 potential benefits associated with magic mushrooms:

1. Alleviation of mental health disorders

Psilocybin has showed promise in the treatment of a variety of mental health problems such as depression, anxiety, and post-traumatic stress disorder (PTSD). It can help to create a positive outlook, alleviate symptoms, and improve emotional well-being.

2. Spiritual and personal growth

For millennia, magical mushrooms have been employed in religious and spiritual practices. They can promote deep introspection, mystical experiences, and a sense of oneness. Following a psychedelic trip, many people experience improved self-awareness, empathy, and a greater appreciation for life.

3. Enhanced creativity and problem-solving

Psilocybin has the ability to boost divergent thinking and creativity. It has been associated to improved problem-solving ability, higher cognitive flexibility, and novel discoveries. These effects may be especially useful in sectors that need creativity and inventiveness.

4. Addiction treatment

According to research, psilocybin-assisted treatment may help people overcome addictions to substances including alcohol, tobacco, and opiates. It can assist people in gaining fresh perspectives, breaking negative mental habits, and increasing motivation for change.

5. Reduced existential distress in terminal illness

Magic mushrooms have showed promise in alleviating existential anguish and anxiety in those suffering from life-threatening illnesses. Psilocybin can bring a sense of calm, acceptance, and a new perspective on death.

Microdosing is not explicitly regulated or legalized in Canada. Substances like psilocybin and LSD are classified as controlled drugs, and their possession, distribution, or consumption is generally illegal without authorization or a prescription.

However, there have been exemptions granted for specific individuals and organizations to study the therapeutic potential of substances like psilocybin. It’s essential to stay updated on current laws and consult official sources for accurate information on microdosing legality in Canada.

Where Can You Buy Microdosing Capsules In Canada?

You want to purchase Microdose Capsules in Canada? There are two possibilities available to you.

Online Retailers

One of the easiest methods to purchase microdosing capsules is through reputable online retailers. These stores offer a variety of substances such as LSD, psilocybin mushrooms, and DMT in capsule form. A trusted online retailer for acquiring Magic Mushroom microdosing capsules is Microdosify.

Nowadays, microdosing has become closely associated with medicine, as it offers potential benefits in that domain.

While there are advantages to buying from an online retailer, it is important to consider the potential drawbacks. One such drawback is the cost of shipping, which can be expensive depending on your location. Moreover, it is crucial to note that certain online retailers may have restrictions on shipping to certain countries due to legal regulations.

However, Microdosify stands out as a highly reputable online retailer specializing in microdosing products.

Psychedelic Societies and Communities

An alternative avenue for purchasing microdosing capsules is through psychedelic societies or communities. These organizations often possess connections to chemists who can create customized blends of psychedelics designed specifically for microdosing purposes. Furthermore, these custom blends tend to be more affordable compared to other options available.

However, it is important to exercise caution and diligence when seeking a reputable source through a psychedelic society or community. Conduct thorough research before making a purchase to ensure the legitimacy and quality of the products obtained.

Read This Before buying Psychedelic Drugs

Psilocybin mushrooms, or magic mushrooms, can have physical and mental effects. Physical effects include dilated pupils, drowsiness, increased heart rate, and nausea. Mental effects range from distorted reality to euphoria, hallucinations, and paranoia.

Long-term personality changes and flashbacks have been reported. Mistaken identity with poisonous mushrooms can be dangerous, and contamination of mushroom products is a concern. Tolerance develops quickly with regular use, requiring higher doses for the same effect.

Overdose symptoms may include agitation, vomiting, and seizures. The effects typically last 6 to 12 hours, and psilocybin can be detected in hair follicles for up to 90 days.

Psilocybin is not considered addictive, but some may experience psychological effects when discontinuing use. Further research is needed to fully understand the long-term risks of magic mushrooms.

Final thoughts

In conclusion, there have been a lot of changes in the last few years about magic mushrooms and microdosing in Canada. Canada has taken steps to make the use of psilocybin, the active ingredient in magic mushrooms, for medical purposes less illegal and legal.

This change in policy was caused by more scientific research and public interest in how psychedelic drugs might help mental health. Even though the rules about magic mushrooms are still changing, Canada has become a leader in researching how these substances might be used as medicine.

Researchers, medical professionals, and people looking for alternative ways to treat mental health problems are living in an exciting time. But it’s important to remember that caution and responsible use are still very important.

Author Microdosify

By Rachel Grey

I’m Rachel Grey, a Ph.D. psychologist specializing in psychedelic therapy with psilocybin and natural plant medicines. I obtained my doctorate from the University of Toronto, where I immersed myself in the study of these transformative therapies. With over 10 years of experience, let’s embark on transformative journeys of healing, growth, and self-discovery as we explore the power of psychedelic therapy together.

Updated on November 15, 2022